The Recall Desk
ModerateFDA (Drugs)·D-0187-2018·Announced 2018-01-17

KRS Global Biotechnology Recalls Prednisolone Tablets Due to Labeling Errors

KRS Global Biotechnology is recalling 3,000 Prednisolone 10 mg tablets because the expiration date exceeds the stability of an ingredient.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error regarding expiration dates, which fits the criteria for moderate severity involving minor labeling errors.

Plain-English summary

KRS Global Biotechnology, Inc. is recalling 3,000 tablets of Prednisolone 10 mg. The recall was initiated due to a labeling error where the Beyond Use Date (BUD) exceeds the expiration date of at least one ingredient used to make the final product.

The affected product is distributed nationwide in the USA, Bermuda, and New Zealand. The specific lot number is 07172017@40, and the Beyond Use Date is January 13, 2018.

Consumers who have this product should stop using it and contact their healthcare provider or pharmacist for further instructions.

The recalled product

Product
PrednisoLONE 10 mg Tablet, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.
Affected units
3,000

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot: 07172017@40 BUD: 1/13/2018

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 47 recalled by KRS Global Biotechnology, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 47 products in this recall →